Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

BACKGROUND: Inflammatory bowel disease (IBD) treatment paradigms recommend objective disease activity assessment and reactive therapeutic drug monitoring (TDM) prior to changes in biologic therapy. We aimed to describe objective marker and TDM assessment in routine clinical practice prior to biologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Click, Benjamin, Barnes, Edward L., Cohen, Benjamin L., Sands, Bruce E., Hanson, John S., Rubin, David T., Dubinsky, Marla C., Regueiro, Miguel, Gazis, Derek, Crawford, Julie M., Long, Millie D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858477/
https://www.ncbi.nlm.nih.gov/pubmed/35183108
http://dx.doi.org/10.1186/s12876-022-02143-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858477/
https://www.ncbi.nlm.nih.gov/pubmed/35183108
http://dx.doi.org/10.1186/s12876-022-02143-x

Ejemplares similares